Emcure Pharmaceuticals share price jumped over 5% to hit a fresh 52-week high on Wednesday after domestic brokerage firm Kotak Institutional Equities initiated coverage on the stock with a bullish view. Kotak has assigned ‘Add’ rating to Emcure Pharmaceuticals shares with a target price of ₹1,655 per share, implying an upside potential of 11% from Tuesday’s closing price. Emcure Pharma …
Emcure Pharmaceuticals IPO listing is scheduled for tomorrow. Emcure Pharma IPO saw strong response and as per BSE data, the subscription status was 67.87 times. Emcure Pharmaceuticals IPO GMP Ahead of the listing, Emcure Pharma IPO GMP on July 9 is +352 which indicates that the company's share price was trading at a premium of ₹352 in the grey market, …
